NOVO.B.DK

228.9

-1.23%↓

GMAB.DK

1,698

+2.01%↑

HLUNB.DK

38.76

+1.73%↑

ZEAL.DK

286.2

-1.65%↓

AMBUB.DK

68

-1.88%↓

NOVO.B.DK

228.9

-1.23%↓

GMAB.DK

1,698

+2.01%↑

HLUNB.DK

38.76

+1.73%↑

ZEAL.DK

286.2

-1.65%↓

AMBUB.DK

68

-1.88%↓

NOVO.B.DK

228.9

-1.23%↓

GMAB.DK

1,698

+2.01%↑

HLUNB.DK

38.76

+1.73%↑

ZEAL.DK

286.2

-1.65%↓

AMBUB.DK

68

-1.88%↓

NOVO.B.DK

228.9

-1.23%↓

GMAB.DK

1,698

+2.01%↑

HLUNB.DK

38.76

+1.73%↑

ZEAL.DK

286.2

-1.65%↓

AMBUB.DK

68

-1.88%↓

NOVO.B.DK

228.9

-1.23%↓

GMAB.DK

1,698

+2.01%↑

HLUNB.DK

38.76

+1.73%↑

ZEAL.DK

286.2

-1.65%↓

AMBUB.DK

68

-1.88%↓

Search

Coloplast A-S (Class B)

Atidarymo kaina

436.5 1.18

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

430.2

Max

439.7

Pagrindiniai rodikliai

By Trading Economics

Pajamos

522M

1.4B

Pardavimai

83M

7B

P/E

Sektoriaus vid.

24.382

57.05

Pelnas, tenkantis vienai akcijai

6.32

Dividendų pajamingumas

5.47

Pelno marža

19.835

Darbuotojai

16,983

EBITDA

309M

2.3B

Rekomendacijos

By TipRanks

Rekomendacijos

Neutralu

12 mėnesių prognozė

+11.86% upside

Dividendai

By Dow Jones

Dividendų pajamingumas

Sektoriaus vid.

5.47%

2.52%

Kitas uždarbis

2026-05-12

Kitas dividendų mokėjimo data

2026-05-20

Kita Ex Dividend data

2026-05-18

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

-21B

97B

Ankstesnė atidarymo kaina

435.32

Ankstesnė uždarymo kaina

436.5

Coloplast A-S (Class B) Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-03-26 23:43; UTC

Rinkos pokalbiai

Nikkei May Decline Amid Uncertainty Over Iran Peace Talks -- Market Talk

2026-03-26 23:36; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Gold Rises Amid Signs of Easing Middle East Tensions -- Market Talk

2026-03-26 23:35; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard: Confirms Discussions With Brown-Forman

2026-03-26 23:29; UTC

Uždarbis

Haier Smart Home: Company to Finance Share Buybacks Via Internal Funds >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans A Share Buybacks of CNY3.0B-CNY6.0B >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans to Increase Payout Ratio to 60% for 2027, 2028 >600690.SH

2026-03-26 23:28; UTC

Uždarbis

Haier Smart Home Plans Cash Dividend Payout Ratio of Up to 58% for 2026 >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Net CNY19.55B Vs. Net CNY18.73B >600690.SH

2026-03-26 23:27; UTC

Uždarbis

Haier Smart Home 2025 Rev CNY302.33B Vs. CNY286.01B >600690.SH

2026-03-26 23:08; UTC

Rinkos pokalbiai

Infratil's Investor Day Addresses Data-Center Issues -- Market Talk

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod Ricard in Talks to Combine With Jack Daniel's Maker Brown-Forman -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Families Behind Pernod, Brown-Forman Would Each Likely Retain Significant Stakes, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod, Brown-Forman Discussing Mostly Stock Deal, Source Says -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod-Brown-Forman Deal Announcement Could Be Weeks Away, Sources Say -- WSJ

2026-03-26 23:04; UTC

Įsigijimai, susijungimai, perėmimai

Pernod in Deal Talks With Brown-Forman -- WSJ

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: No Agreement Has Been Reached as to Terms of Any Possible Pernod Ricard Transaction

2026-03-26 22:41; UTC

Įsigijimai, susijungimai, perėmimai

Brown-Forman: Synergies From Contemplated Pernod Ricard Combination Expected to Be Significant

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Rev CNY544.62B Vs. CNY516.61B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper 2025 Net CNY7.13B Vs. Net CNY6.96B >0358.HK

2026-03-26 22:26; UTC

Uždarbis

Jiangxi Copper Higher Demand For Products Supported Results>0358.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Loss CNY1.79B Vs. Loss CNY232.56M >0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China Impairment Loss on Goodwill Weighed on Results>0753.HK

2026-03-26 22:08; UTC

Uždarbis

Air China 2025 Rev CNY171.48B Vs. CNY166.70B >0753.HK

2026-03-26 22:07; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Global Energy Roundup: Market Talk

2026-03-26 22:07; UTC

Rinkos pokalbiai
Svarbiausios naujienos

Open-Pit Gold Miners Most Exposed to High Fuel Prices -- Market Talk

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Net CNY4.59B Vs. Net CNY4.34B >0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery: Higher Volume Sales of Beer Supported Results>0168.HK

2026-03-26 22:00; UTC

Uždarbis

Tsingtao Brewery 2025 Rev CNY32.47B Vs. CNY32.14B >0168.HK

2026-03-26 21:39; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Sees Early Indications of Strong Interest in Site Adjacent Western Port

2026-03-26 21:38; UTC

Įsigijimai, susijungimai, perėmimai

BlueScope: Has Begun Expression of Interest Process For 65-Hectare Site Adjacent Western Port

Akcijų palyginimas

Kainos pokytis

Coloplast A-S (Class B) Prognozė

Kainos tikslas

By TipRanks

11.86% į viršų

12 mėnesių prognozė

Vidutinis 901.38 DKK  11.86%

Aukščiausias 1,056 DKK

Žemiausias 720 DKK

Remiantis 8 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Coloplast A-S (Class B) kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Neutralu

8 ratings

2

Pirkti

4

Laikyti

2

Parduoti

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat